In the second episode, panic strikes the community as a full-blown catastrophe looms. Locals mobilize to confront the authorities and protest the nuclear power industry.
Twenty-eight hours after the accident began, the lieutenant governor appeared at a news briefing to say that the plant's owner had assured the state that 'everything is under control'. Later that day, Scranton changed his statement, saying that the situation was 'more complex than the company first led us to believe'. There were conflicting statements about radioactivity releases. Schools were closed and residents were urged to stay indoors. Farmers were told to keep their animals under cover and on stored feed.

In the third episode, during cleanup at the plant, insiders claim that cost-cutting measures and intimidation tactics create a danger war force than the accident itself.
Several state and federal government agencies mounted investigations into the crisis, the most prominent of which was the President's Commission on the Accident at Three Mile Island, headed by chairman John G. Kemeny. The investigation strongly criticized Babcock & Wilcox, Met Ed, Graphics processing unit, and the Nuclear Regulatory Commission for lapses in quality assurance and maintenance, inadequate operator training, lack of communication of important safety information, poor management, and complacency.
Kemeny said that the procedures and that the control room were greatly inadequate for managing an accident.

As NASA releases the first images from the James Webb Space Telescope, this film tells the inside story of the telescope's construction and the astronomers taking its first picture of distant stars and galaxies. Will it be the deepest image of our universe ever taken? The successor to Hubble, and 100 times more powerful, the James Webb is the most technically advanced telescope ever built. It will look further back in time than Hubble to an era around 200 million years after the Big Bang, when the first stars and galaxies appeared. Webb's primary mission is to capture the faint light from these objects on the edge of our visible universe so that scientists can learn how they formed, but its instruments are so sensitive it could also be the first telescope to detect signs of life on a distant planet.
The James Webb Telescope is an £8 billion gamble on the skills of its engineering team. It’s the first telescope designed to unfold in space – a complicated two-week operation in which 178 release devices must all work - 107 of them on the telescope's sun shield alone. If just one fails, the expensive telescope could become a giant piece of space junk.
From its conception in the late 1980s, the construction of Webb has posed a huge technical challenge. The team must build a mirror six times larger than Hubble’s and construct a vast sun shield the size of a tennis court, fold them up so they fit into an Ariane 5 rocket, then find a way to unfold them in space. This film tells the inside story of the James Webb Space Telescope in the words of the engineers who built it and the astronomers who will use it.

This highly anticipated psychedelic docuseries showcases what these substances teaches people about consciousness, dying, addiction, depression and transcendence. Filmmaker Alex Gibney and best-selling author Michael Pollan present it in four parts, each focused on a different mind-altering substance: LSD, psilocybin, MDMA, and mescaline. With Pollan as our guide, we journey to the frontiers of the new psychedelic renaissance -- and look back at almost-forgotten historical context -- to explore the potential of these substances to heal and change minds as well as culture.
The first chapter is a great introduction to the topic of LSD, from its 1943 origins to today's microdosing trend, for those who don’t already know a lot about the subject, and a fun and entertaining refresher on LSD for even experts in the field. The show takes us on a journey through the history of the powerful compound, from its discovery and its early medical use, to secret CIA mind-control studies, the counterculture and its banning, and finally to our current renaissance. It includes amazing clips of LSD’s inventor Albert Hofmann and powerful personal testimonies of individuals who have healed their suffering through LSD.

Magic mushrooms, long considered sacred by the Indigenous Mazatec in Mexico, become the subject of scientific studies measuring the intense effects of its Psilocybin and its potential therapeutic use.
In the second episode, we are introduced to Ben, who’s battled with crippling Obsessive-Compulsive Disorder (OCD) his entire life. When he had his firstborn, Ben’s life became full of panic attacks regarding his son’s safety, and he knew something had to change. Ben signed up for a psilocybin-assisted therapy clinical trial which was testing whether the psychedelic could help people with severe OCD. In the session under the influence of psilocybin, Ben felt decomposed and eventually grew into a tree. While living as a tree, he saw his human self, playing with his child. Though this sounds scary, from Ben’s perspective, it was beautiful. He was one with the universe, seeing himself in the ultimate third-person perspective. Finally, he saw how it could be different if he didn’t let his OCD control him. And several months out, all the symptoms disappeared.
Ben’s story is one of many told in this series, which gives hope that help is right around the corner for the millions who suffer —often in silence— with debilitating mental disorders. But Michael Pollan’s work is showcasing the success stories. Often, even in the most successful trials, psychedelic-assisted therapy only helps up to a third of people enter remission. More frequently, patients are helped —sometimes substantially— but they still suffer with their illnesses and some people aren’t helped at all.

Championed by both therapists and ravers, ecstasy stands out as the first psychedelic likely to become legalized, thanks to passionate advocates.
The episode about 3,4-Methylenedioxymethamphetamine (MDMA), is focused on Multidisciplinary Association for Psychedelic Studies (MAPS) clinical trials treating Post-traumatic stress disorder (PTSD).